KROS logo

KROS

Keros Therapeutics Inc.

$15.21
-$0.04(-0.26%)
35
Overall
--
Value
40
Tech
31
Quality
Market Cap
$605.58M
Volume
586.02K
52W Range
$9.12 - $72.37
Target Price
$23.33
Order:

Income Statement

MetricTrendChart
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
--$20.1M--$151.0K$3.5M
Total Revenue
--$20.1M--$151.0K$3.5M
GROSS PROFIT
Gross Profit
--$20.1M--$151.0K$3.5M
OPERATING EXPENSES
Operating Expenses
$46.7M$76.5M$107.7M$170.1M$214.4M
Research & Development
$33.9M$55.1M$87.3M$135.3M$173.6M
Research Expense
$33.9M$55.1M$87.3M$135.3M$173.6M
Selling, General & Administrative
$12.8M$21.3M$27.5M$34.8M$40.8M
General & Administrative Expenses
$12.8M$21.3M$27.5M$34.8M$40.8M
Salaries & Wages
----$18.7M$28.8M$34.9M
Depreciation & Amortization
$300.0K$400.0K$700.0K$815.0K$1.2M
Depreciation & Amortization
$300.0K$400.0K$700.0K$815.0K$1.2M
Other Operating Expenses
$468.0K$600.0K$1.6M$4.3M$-1.1M
OPERATING INCOME
Operating income
$-46.7M$-56.4M$-114.8M$-169.9M$-210.8M
EBITDA
$-45.2M$-56.4M$-103.1M$-150.6M$-184.0M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$6.0K$4.0K$1.0K----
Intinc
$-6.0K--------
Net Non-Operating Interest Income/Expense
$-6.0K$-4.0K$-1.0K----
Other Income/Expense
$-1.2M$356.0K$3.0M$206.0K$954.0K
Other Special Charges
$2.7M$-356.0K$-613.0K$-206.0K$-954.0K
SPECIAL ITEMS
Special Income Charges
----$3.6M$14.8M$23.5M
PRE-TAX INCOME
EBIT
$-45.5M$-56.7M$-104.7M$-153.0M$-187.1M
Pre-Tax Income
$-45.5M$-56.7M$-104.7M$-153.0M$-187.1M
INCOME TAX
Tax Provision
$-172.0K$2.0M----$300.0K
NET INCOME
Net Income
$-45.4M$-58.7M$-104.7M$-153.0M$-187.4M
Net Income (Continuing Operations)
$-45.4M$-58.7M$-104.7M$-153.0M$-187.4M
Net Income (Discontinued Operations)
$-45.4M$-58.7M$-104.7M$-153.0M$-187.4M
Net Income (Common Stockholders)
$-45.4M$-58.7M$-104.7M$-153.0M$-187.4M
Normalized Income
--------$-208.7M
TOTALS
Total Expenses
$46.7M$76.5M$107.7M$170.1M$214.4M
SHARE & EPS DATA
Average Shares Outstanding
$15.5M$23.3M$25.2M$29.4M$37.4M
Average Shares Outstanding (Diluted)
$15.5M$23.3M$25.2M$29.4M$37.4M
Shares Outstanding
$23.3M$40.6M$28.5M$36.0M$40.6M
Basic EPS
$-2.93$-2.52$-4.15$-5.2$-5
Basic EPS (Continuing Operations)
$-2.93$-2.52$-4.15$-5.2$-5
Diluted EPS
$-2.93$-2.52$-4.15$-5.2$-5
Diluted EPS (Continuing Operations)
--$-2.52$-4.15$-5.2$-5
OTHER METRICS
Accrued Preferred Stock Dividends
$45.4M$58.7M$104.7M$153.0M$187.4M
Other Gand A
$12.8M$21.3M$27.5M$34.8M$40.8M
Otherunder Preferred Stock Dividend
$45.4M$58.7M$104.7M$153.0M$187.4M
Preferred Stock Dividends
$45.4M$58.7M$104.7M$153.0M$187.4M
Othspecchg
----$-3.6M$-14.8M$-23.5M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2KROS$15.21-0.3%586.02K
3
4
5
6

Get Keros Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.